ALECTOR INC. - COMMON STOCK

Alector to Participate in Upcoming Healthcare Conferences

28 8月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

07 8月 2025 13:05:02 条件 Nasdaq GlobeNewswire

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

31 7月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

13 6月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

03 6月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

08 5月 2025 13:05:03 条件 Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

06 5月 2025 05:00:02 条件 Nasdaq GlobeNewswire

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

17 4月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

28 3月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

26 2月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

25 2月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

19 2月 2025 13:05:00 条件 Nasdaq GlobeNewswire

Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025

13 1月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

25 11月 2024 13:05:00 条件 Nasdaq GlobeNewswire

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

14 11月 2024 13:05:46 条件 Nasdaq GlobeNewswire

Alector Reports Third Quarter 2024 Financial Results and Provides Business Update

06 11月 2024 13:05:00 条件 Nasdaq GlobeNewswire

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

19 9月 2024 05:00:00 条件 Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

29 8月 2024 04:00:00 条件 Nasdaq GlobeNewswire

Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

07 8月 2024 13:05:00 条件 Nasdaq GlobeNewswire

Alector to Host Mid-Year Earnings Conference Call

31 7月 2024 13:05:00 条件 Nasdaq GlobeNewswire